These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10672208)

  • 1. Detection of praziquantel resistance in schistosomes.
    Liang YS; Coles GC; Doenhoff MJ
    Trop Med Int Health; 2000 Jan; 5(1):72. PubMed ID: 10672208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
    Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
    Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
    Lamberton PHL; Faust CL; Webster JP
    Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
    Abo-Ghalia MH; Soliman AE
    Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
    Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
    Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in schistosomiasis.
    Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
    Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic analysis of praziquantel resistance in Schistosoma mansoni.
    Liang YS; Dai JR; Zhu YC; Coles GC; Doenhoff MJ
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):274-80. PubMed ID: 12971549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection.
    Utzinger J; N'Goran EK; N'Dri A; Lengeler C; Tanner M
    Trop Med Int Health; 2000 Nov; 5(11):771-8. PubMed ID: 11123824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 15. A Search for Snail-Related Answers to Explain Differences in Response of
    Mutuku MW; Laidemitt MR; Beechler BR; Mwangi IN; Otiato FO; Agola EL; Ochanda H; Kamel B; Mkoji GM; Steinauer ML; Loker ES
    Am J Trop Med Hyg; 2019 Jul; 101(1):65-77. PubMed ID: 31162012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
    Shu-Hua X; Utzinger J; Chollet J; Tanner M
    Int J Parasitol; 2006 Jul; 36(8):957-64. PubMed ID: 16750833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
    Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
    Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
    Xiao SH; Sun J; Chen MG
    Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
    Panic G; Ruf MT; Keiser J
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic vesicles of Schistosoma mansoni.
    Carneiro-Santos P; Thornhill JA; Doenhoff MJ; Hagan P; Kusel JR
    Parasitol Res; 2001 Dec; 87(12):1001-6. PubMed ID: 11763428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.